Total Visits

Views
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice84

Select a period of time:

Views

Views
July 202522
August 20250
September 20253
October 20259
November 20257
December 20254
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil11
United Kingdom5
Finland2
Kenya2
Turkey2
Argentina2
Germany1
Ecuador1
Morocco1
 

Top cities views

Views
Nairobi2
São Paulo2
Teresina2
Helsinki2
Agadir1
Botucatu1
Buenos Aires1
Caracas1
Englewood1
Garanhuns1